Top

Surgical Endoscopy

Published in:

01-08-2012

The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease

Authors: Ewen A. Griffiths, Catherine J. Gregory, Kishore G. Pursnani, Jeremy B. Ward, Robert C. Stockwell

Published in: Surgical Endoscopy | Issue 8/2012

Abstract

Background

Biodegradable (BD) oesophageal stents have been available commercially only since 2008 and previous published research is limited. Our aim was to review the use of BD stents to treat dysphagia in benign or malignant oesophageal strictures.

Methods

Patients were identified from a prospective interventional radiological database. BD stents were inserted radiologically under fluoroscopic control.

Results

Between July 2008 and February 2011, 25 attempts at placing SX-ELLA biodegradable oesophageal stents were made in 17 males and five females, with a median age of 69 (range = 54–80) years. Two patients required more than one BD stent. Indications were benign strictures (n = 7) and oesophageal cancer (n = 17). One attempt was unsuccessful for a technical success rate of 96% with no immediate complications. Clinical success rate was 76%. Median dysphagia score before stent insertion was 3 (range = 2–4) compared to 2 (range = 0–3) after stent insertion (p = 0.0001).

Conclusion

BD stents provide good dysphagia relief for the life time of the stent. They may help avoid the use of feeding tubes in patients having radical chemoradiotherapy or awaiting oesophagectomy. They do not require removal or interfere with radiotherapy planning via imaging. However, the reintervention rate is high after the stent dissolves.

Burstow M, Kelly T, Panchani S, Khan IM, Meek D, Memon B, Memon MA (2009) Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis. Dis Esophagus 22:519–525PubMedCrossRef

Stivaros SM, Williams LR, Senger C, Wilbraham L, Laasch HU (2010) Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures. Eur Radiol 20:1069–1072PubMedCrossRef

Repici A, Vleggaar FP, Hassan C, van Boeckel PG, Romeo F, Pagano N, Malesci A, Siersema PD (2010) Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (biodegradable esophageal stent) study. Gastrointest Endosc 72:927–934PubMedCrossRef

Mellow MH, Pinkas H (1985) Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy. Arch Intern Med 145:1443–1446PubMedCrossRef

Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062–5067PubMedCrossRef

Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef

Hair CS, Devonshire DA (2010) Severe hyperplastic tissue stenosis of a novel biodegradable esophageal stent and subsequent successful management with high-pressure balloon dilation. Endoscopy 42(Suppl 2):E132–E133PubMedCrossRef

Eberhart RC, Su SH, Nguyen KT, Zilberman M, Tang L, Nelson KD, Frenkel P (2003) Bioresorbable polymeric stents: current status and future promise. J Biomater Sci Polym Ed 14:299–312PubMedCrossRef

Fry SW, Fleischer DE (1997) Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 45:179–182PubMedCrossRef

10.

Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53:330–333PubMedCrossRef

11.

Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (2007) Usefulness of biodegradable stents constructed of poly-L-lactic acid monofilaments in patients with benign esophageal stenosis. World J Gastroenterol 13:3977–3980PubMed

12.

Vandenplas Y, Hauser B, Devreker T, Urbain D, Reynaert H (2009) A biodegradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child. J Pediatr Gastroenterol Nutr 49:254–257PubMedCrossRef

13.

Ackroyd R, Watson DI, Devitt PG, Jamieson GG (2001) Expandable metallic stents should not be used in the treatment of benign esophageal strictures. J Gastroenterol Hepatol 16:484–487PubMedCrossRef

14.

Bakken JC, Wong Kee Song LM, de Groen PC, Baron TH (2010) Use of a fully covered self-expandable metal stent for the treatment of benign esophageal diseases. Gastrointest Endosc 72:712–720PubMedCrossRef

15.

Griffiths EA, Gregory CJ, Stockwell RC (2011) Case study: The use of SX-ELLA BD oesophageal stent to treat dysphagia caused by a benign oesophageal stricture. Web publication, UK Medical Sheffield, UK. http://www.ukmedical.com/images/pdf/s_cs_griff_v1_0111.pdf. Accessed Jan 2011

16.

Brown RE, Abbas AE, Ellis S, Williams S, Scoggins CR, McMasters KM, Martin RC 2nd (2011) A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 212:582–588 discussion 588–589PubMedCrossRef

17.

Pellen MG, Sabri S, Razack A, Gilani SQ, Jain PK (2012) Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer. Dis Esophagus 25:48–53PubMedCrossRef

18.

Li XA, Chibani O, Greenwald B, Suntharalingam M (2002) Radiotherapy dose perturbation of metallic esophageal stents. Int J Radiat Oncol Biol Phys 54:1276–1285PubMedCrossRef

19.

Shin JH, Song HY, Kim JH, Kim SB, Lee GH, Park SI, Han YM, Kang W (2005) Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma. J Vasc Interv Radiol 16:67–74PubMedCrossRef

20.

Song HY, Lee DH, Seo TS, Kim SB, Jung HY, Kim JH, Park SI (2002) Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol 13:285–293PubMedCrossRef

21.

Bozzetti F (2008) Quality of life and enteral nutrition. Curr Opin Clin Nutr Metab Care 11:661–665PubMedCrossRef

22.

Siddiqui AA, Loren D, Dudnick R, Kowalski T (2007) Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci 52:823–829PubMedCrossRef

23.

Christie NA, Buenaventura PO, Fernando HC, Nguyen NT, Weigel TL, Ferson PF, Luketich JD (2001) Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg 71:1797–1801 discussion 1801–1792PubMedCrossRef

24.

Lopes TL, Eloubeidi MA (2010) A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer. Dis Esophagus 23:309–315PubMedCrossRef

25.

Shenfine J, McNamee P, Steen N, Bond J, Griffin SM (2009) A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol 104:1674–1685PubMedCrossRef

26.

Dallal HJ, Smith GD, Grieve DC, Ghosh S, Penman ID, Palmer KR (2001) A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 54:549–557PubMedCrossRef

27.

Maruthachalam K, Lash GE, Shenton BK, Horgan AF (2007) Tumour cell dissemination following endoscopic stent insertion. Br J Surg 94:1151–1154PubMedCrossRef

28.

Goldin E, Fiorini A, Ratan Y (1996) A new biodegradable and self-expandable stent for benign esophageal stricture. Gastrointest Endosc 43:294CrossRef

29.

Tanaka T, Takahashi M, Nitta N, Furukawa A, Andoh A, Saito Y, Fujiyama Y, Murata K (2006) Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74:199–205PubMedCrossRef

30.

Cerna M, Kocher M, Valek V, Aujesky R, Neoral C, Andrasina T, Panek J, Mahathmakanthi S (2011) Covered biodegradable stent: new therapeutic option for the management of esophageal perforation or anastomotic leak. Cardiovasc Interv Radiol 34:1267–1271CrossRef

31.

van Hooft JE, van Berge Henegouwen MI, Rauws EA, Bergman JJ, Busch OR, Fockens P (2011) Endoscopic treatment of benign anastomotic esophagogastric strictures with a biodegradable stent. Gastrointest Endosc 73:1043–1047PubMedCrossRef

32.

van Boekel PG, Vieggar FP, Swsema PD (2011) A comparison of temporary self-expanding plastic and biodegradable stents for refactory benign esophagel strictures. Clin Gastroenterol hepatol 9(8):653–659

Title: The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease
Authors: Ewen A. Griffiths
Catherine J. Gregory
Kishore G. Pursnani
Jeremy B. Ward
Robert C. Stockwell
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 8/2012
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-012-2192-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2012

Bilateral thoracoscopic splanchnicectomy for pain in patients with chronic pancreatitis impairs adrenomedullary but not noradrenergic sympathetic function

Surgical techniques of laparoscopic peritonectomy plus paraaortic lymph node dissection for the treatment of patients with positive lymph node metastasis and peritoneal seeding from rectosigmoid cancer

Robotic transaxillary endocrine surgery: a comparison with conventional open technique

The optimal strategy for proximal mesh fixation during laparoscopic ventral rectopexy for rectal prolapse: an ex vivo study

Laparoscopic common bile duct exploration versus open surgery: comparative prospective randomized trial

Magnifying endoscopy for diagnosis of residual/local recurrent gastric neoplasms after previous endoscopic treatment